Nuwellis, Inc.
NUWENasdaqCIK 1506492HealthcareFiscal year ends Dec 31
Reports and events: 405 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2309:18 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-040605 |
| 2026-08-2621:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-034367 |
| 2026-08-1316:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032838 |
| 2026-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001140361-26-032810 |
| 2026-08-0316:35 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-030985 |
| 2026-07-2416:15 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-029609 |
| 2026-07-0716:30 ET | DEF 14A | Proxy statementPeriod 2026-07-07 | 0001539497-26-001914 |
| 2026-06-2417:47 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-026114 |
| 2026-06-1817:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025614 |
| 2026-06-1009:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-024740 |
| 2026-06-0413:04 ET | S-1/A | Registration statement, amended | 0001140361-26-023964 |
| 2026-05-2917:28 ET | S-1/A | Registration statement, amended | 0001140361-26-023354 |
| 2026-05-2217:09 ET | S-1 | Registration statement | 0001140361-26-022629 |
| 2026-05-1516:01 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001140361-26-021649 |
| 2026-05-1216:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020805 |
| 2026-04-2916:30 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-017826 |
| 2026-04-2417:00 ET | 8-K | 8.01 Other events | 0001140361-26-016755 |
| 2026-04-0217:01 ET | DEF 14A | Proxy statementPeriod 2026-04-28 | 0001539497-26-001081 |
| 2026-04-0116:45 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-012781 |
| 2026-03-2716:55 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-011775 |
| 2026-03-1709:13 ET | 8-K | 8.01 Other events | 0001140361-26-009745 |
| 2026-03-1117:24 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-009080 |
| 2026-03-1016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-008781 |
| 2026-02-2608:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006888 |
| 2026-01-3009:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002906 |
| 2026-01-2317:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002241 |
| 2025-11-1216:19 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041651 |
| 2025-11-1211:49 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041591 |
| 2025-10-0817:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-037713 |
| 2025-09-3008:55 ET | 8-K | 8.01 Other events | 0001140361-25-036651 |
| 2025-09-1809:18 ET | 8-K | 8.01 Other events | 0001140361-25-035346 |
| 2025-09-0909:20 ET | 8-K | 8.01 Other events | 0001140361-25-034368 |
| 2025-09-0308:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-033738 |
| 2025-08-2108:55 ET | 8-K | 8.01 Other events | 0001140361-25-032150 |
| 2025-08-1908:52 ET | 8-K | 8.01 Other events | 0001140361-25-031828 |
| 2025-08-1416:03 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-031209 |
| 2025-08-1411:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-031093 |
| 2025-08-0417:15 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-028670 |
| 2025-07-2308:50 ET | 8-K | 8.01 Other events | 0001140361-25-026855 |
| 2025-07-1408:55 ET | DEF 14A | Proxy statementPeriod 2025-08-04 | 0001539497-25-001825 |
| 2025-07-0208:49 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-024517 |
| 2025-06-2316:40 ET | 8-K | 3.01 Delisting notice | 0001140361-25-023368 |
| 2025-06-1620:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001140361-25-022709 |
| 2025-06-0909:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-021870 |
| 2025-06-0320:42 ET | S-1/A | Registration statement, amended | 0001140361-25-021187 |
| 2025-05-3009:26 ET | S-1 | Registration statement | 0001140361-25-020878 |
| 2025-05-2216:40 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-020182 |
| 2025-05-1317:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-018676 |
| 2025-05-1311:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-018543 |
| 2025-05-1216:45 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-25-018404 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.